- Home
- HUYA vs VSTM Comparison
HUYA vs VSTM Comparison
Compare HUYA & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUYA
- VSTM
- Stock Information
- Founded
- HUYA 2014
- VSTM 2010
- Country
- HUYA China
- VSTM United States
- Employees
- HUYA N/A
- VSTM N/A
- Industry
- HUYA Computer Software: Programming Data Processing
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- HUYA Technology
- VSTM Health Care
- Exchange
- HUYA Nasdaq
- VSTM Nasdaq
- Market Cap
- HUYA 713.8M
- VSTM 581.6M
- IPO Year
- HUYA 2018
- VSTM 2012
- Fundamental
- Price
- HUYA $2.68
- VSTM $7.70
- Analyst Decision
- HUYA Strong Buy
- VSTM Strong Buy
- Analyst Count
- HUYA 2
- VSTM 9
- Target Price
- HUYA $4.25
- VSTM $13.38
- AVG Volume (30 Days)
- HUYA 936.8K
- VSTM 2.8M
- Earning Date
- HUYA 11-12-2025
- VSTM 11-04-2025
- Dividend Yield
- HUYA 92.74%
- VSTM N/A
- EPS Growth
- HUYA N/A
- VSTM N/A
- EPS
- HUYA N/A
- VSTM N/A
- Revenue
- HUYA $852,782,043.00
- VSTM $13,379,000.00
- Revenue This Year
- HUYA $8.16
- VSTM $88.60
- Revenue Next Year
- HUYA $5.11
- VSTM $416.99
- P/E Ratio
- HUYA N/A
- VSTM N/A
- Revenue Growth
- HUYA N/A
- VSTM 33.79
- 52 Week Low
- HUYA $2.21
- VSTM $3.46
- 52 Week High
- HUYA $4.59
- VSTM $11.25
- Technical
- Relative Strength Index (RSI)
- HUYA 36.64
- VSTM 41.32
- Support Level
- HUYA $2.65
- VSTM $7.55
- Resistance Level
- HUYA $2.93
- VSTM $8.86
- Average True Range (ATR)
- HUYA 0.11
- VSTM 0.60
- MACD
- HUYA 0.01
- VSTM -0.07
- Stochastic Oscillator
- HUYA 22.86
- VSTM 14.64
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Huya, officially became independent in 2016 and headquartered in Guangzhou, operates live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. As of 2024, Huya was a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.